Crimean-Congo hemorrhagic fever orthonairovirus Nucleocapsid Protein (CCHFV-NP) - NCP0165

Crimean-Congo hemorrhagic fever orthonairovirus Nucleocapsid Protein (CCHFV-NP)

Catalogue Number: NCP0165

Product: Soluble protein;PBS, PH=7.4

Swiss-Prot: NM_001313894.1

Host: His-tag

Reactivity: E. coli Expression

Applications: Source of infection

All Applications: Reseach

Purification and Purity: Transferred into competent cells and the supernatant was purified by NI column affinity chromatography and the purity is > 85% (by SDS-PAGE).

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in the Congo, thus resulting in the current name of the disease.Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in the Congo, thus resulting in the current name of the disease.Crimean-Congo hemorrhagic fever is found in Eastern Europe, particularly in the former Soviet Union, throughout the Mediterranean, in northwestern China, central Asia, southern Europe, Africa, the Middle East, and the Indian subcontinent.

Notes: For research use only, not for use in diagnostic procedure.

Extra Notes: Carrier: pET30a-CCHFV-NP-His (C-term)
Virus:Mus musculus high mobility group box 1 (Hmgb1)

BioWorld Molecular Weight: 1446bp;61kDa

Sizes: 100ug, 1mg (Contact us about the 1mg size)